Surgical-imaging Research on Obesity (SIRO)
- Conditions
- Overweight and Obesity
- Registration Number
- NCT06268262
- Brief Summary
The global obesity epidemic is well established, and is an important public health issue. The previous researches had applied the clues that obesity is a kind of systemic disease. The investigators hypothesized that a serious alteration of the body systems will occur after bariatric surgery, which may shed light on the mechanisms of obesity. Thus, the research aims to combine the imaging and surgery to investigate the alterations of the body that induced by obese and alterations after surgery.
- Detailed Description
In 2016, the prevalence of obesity has already reached 13% of obesity and about 40% overweight worldwide. There is no doubt that obesity is linked to a broad spectrum of diseases，such as cardiovascular diseases, fatty liver diseases, polycystic ovarian syndrome and even central nervous systems disorders. For instance, in a review, author indicated the insulin resistance of T2DM occurs primarily in the muscles of lean individuals before they become obese. The central nervous system, especially the hypothalamus, has always considered to be the regulation center of food intake and hormonal regulation of energy homeostasis. In turn, obesity may worsen the regularity function of nervous system in several pathway. Based on the previous findings, the investigators hypothesized that a serious alterations of the body systems will occur after bariatric surgery, which may shed light on the mechanisms of obesity. The investigators plan to integrate the MR imaging, biological and epidemiological data thoroughly to investigate the alterations of the body that induced by obese and also followup the alterations that after surgery.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Imaging parameters of obesity baseline, 6th month Fat fraction of liver (dividing the in-phase fat attenuation signal by the out-phase fat attenuation signal)
- Secondary Outcome Measures
Name Time Method Neurotransmitter, inflammatory factors and hormones relating to obesity in blood sample baseline, 6th month The level of BDNF in ng/ml
Neurotransmitter, inflammatory factors and hormones related to obesity in blood sample baseline, 6th month cortisol in μg/L
Genetic information from venous blood sample, biopsied liver tissue, biopsied fat tissue, and gastric tissue baseline Screen and analyzing the DNA and RNA related to obesity
Trial Locations
- Locations (1)
Affiliated Hospital of Xuzhou Medical University
🇨🇳Xuzhou, Jiangsu, China